Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Immuno-Oncology

MDS Session: Women in Science

Myelodysplastic syndromes (MDS) are a heterogenous group of myeloid disorders characterized by the accumulation of dysplastic cells within the bone…

Date: 17th May 2021

Key updates on CAR-T & cellular therapy for AML

Acute myeloid leukemia (AML) is the most common type of leukemia in adults and is highly heterogenous. AML is typically…

Date: 17th May 2021

The MDS Sessions: highlights from ASH 2020

Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by the accumulation of dysplastic cells within the bone…

Date: 27th April 2021

The Transplant Sessions: ASH 2020 highlights

The management of post-transplantation relapse and immune attack is an ongoing battle in patients undergoing bone marrow transplants. The efficacy…

Date: 23rd April 2021

The Lymphoma Sessions: ASH 2020 highlights

The treatment of aggressive lymphomas such as diffuse large B-cell has seen dramatic changes, and with the advent of bispecific…

Date: 23rd April 2021

The Myeloma Sessions: Post-ASH 2020 UK Discussion

The development of immunomodulatory agents and proteasome inhibitors alongside stem cell transplantation and chemotherapy has significantly improved the treatment options…

Date: 19th April 2021

Post-ASH Amyloidosis Session from VJHemOnc

The most common form of amyloidosis, light-chain (AL) amyloidosis, results from abnormalities in plasma cells causing them to produce abnormal…

Date: 13th April 2021

The Post-EBMT VJSessions from VJHemOnc

The 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) was held virtually this year and…

Date: 7th April 2021

Post-EBMT highlights in acute myeloid leukemia

Acute myeloid leukemia (AML) is the most common type of adult leukemia, with over 19,500 new cases estimated to be…

Date: 6th April 2021

The CLL Sessions: highlights from ASH 2020

Chronic lymphocytic leukemia (CLL), also known as B-cell CLL (B-CLL) is the most common leukemia in Europe and North America….

Date: 17th March 2021

The Lymphoma Sessions: highlights from ASH 2020

Lymphoma is a collection of cancers which develop in the lymphatic system and affect the lymphocytes. The risk factors for…

Date: 17th March 2021

VJSession: EBMT/EHA CAR-T Nursing Session

The 3rd European CAR T-cell Meeting, organized by the European Society for Blood and Marrow Transplantation (EBMT), and the European…

Date: 23rd February 2021